Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (3): 405-408    DOI: 10.31083/j.ceog.2020.03.5239
Case Report Previous articles | Next articles
Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders
K. Tamura1, H. Takahashi1, *(), S. Uchida1, M. Ogoyama1, R. Usui1, S. Matsubara1
1Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan
Download:  PDF(513KB)  ( 234 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Several studies indicate that intrauterine balloon (IUB) use is less effective for postpartum hemorrhage (PPH) due to placenta accreta spectrum (PAS) disorders than that due to atonic bleeding. IUB failed to achieve hemostasis because the present two cases had normally positioned PAS. Case Report: A 37-year-old woman was transferred due to PPH. She vaginally delivered. The placenta was without macroscopic defect. Atonic bleeding was suspected. An IUB was placed, without achieving hemostasis. Her status deteriorated, necessitating a hysterectomy. The placenta remained, adhering to the uterine body. Histological examination revealed placenta accreta. The second case was a 40-year-old woman that was transferred due to PPH of atonic bleeding after vaginal delivery. The placenta was without macroscopic defect. An IUB was placed, without hemostasis, and was subsequently was removed. Conservative treatment achieved hemostasis. An Ultrasound revealed the placenta in the uterine body. We diagnosed her with clinical PAS. Nonprevia PAS may be present when an IUB fails to achieve hemostasis.

Key words:  Intrauterine balloon      Hysterectomy      Postpartum hemorrhage      Placenta accreta spectrum      Transfusion     
Submitted:  22 April 2019      Accepted:  24 June 2019      Published:  15 June 2020     
*Corresponding Author(s):  HIRONORI TAKAHASHI     E-mail:  hironori@jichi.ac.jp

Cite this article: 

K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.03.5239     OR     https://ceog.imrpress.com/EN/Y2020/V47/I3/405

Figure 1.  — Clinical course of Case 1. The blood loss (vaginal + from intrauterine balloon drain) steadily increased to as much as 300 mL at one hour after intrauterine balloon use (bold arrow). CS: cesarean section, TAE: transarterial embolization.

Figure 2.  — Macroscopic (a) and microscopic (b) findings in Case 1. Placenta accreta spectrum is observed. A placental fragment adhered to the posterior uterine body (arrow). Chorionic villi directly attached to the myometrium (arrowhead) without decidua, suggesting placenta accreta.

Figure 3.  — Imaging findings in Case 2. Transvaginal ultrasound shows the residual placenta (high-echoic part: star) in the uterus on postpartum day 8. The placenta is retained in the anterior uterus (asterisk) based on magnetic resonance imaging (T1 gadolinium enhanced) on postpartum day 10.

[1] Revert M., Cottenet J., Raynal P., Cibot E., Quantin C., Rozenberg P.: “Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study”. BJOG, 2017, 124, 1255.
doi: 10.1111/1471-0528.14382 pmid: 27781401
[2] Vintejoux E., Ulrich D., Mousty E., Masia F., Mares P., de Tayrac R., et al.: “Success factors for Bakri™ balloon usage secondary to uterine atony: a retrospective, multicentre study”. Aust. N. Z. J. Obstet. Gynaecol., 2015, 55, 572.
doi: 10.1111/ajo.12376 pmid: 26223852
[3] Ogoyama M., Takahashi H., Usui R., Baba Y., Suzuki H., Ohkuchi A., et al.: “Hemostatic effect of intrauterine balloon for postpartum hemorrhage with special reference to concomitant use of “holding the cervix” procedure (Matsubara)”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2017, 210, 281.
doi: 10.1016/j.ejogrb.2017.01.012 pmid: 28088108
[4] Kong C.W., To W.W.: “Prognostic factors for the use of intrauterine balloon tamponade in the management of severe postpartum hemorrhage”. Int. J. Gynaecol. Obstet., 2018, 142, 48.
doi: 10.1002/ijgo.12498 pmid: 29603742
[5] Georgiou C.: “Balloon tamponade in the management of postpartum haemorrhage: a review”. BJOG, 2009, 116, 748.
doi: 10.1111/j.1471-0528.2009.02113.x pmid: 19432563
[6] Brown H., Okeyo S., Mabeya H., Wilkinson J., Schmitt J.: “The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage”. Int. J. Gynaecol. Obstet., 2016, 135, 276.
doi: 10.1016/j.ijgo.2016.06.021 pmid: 27612530
[1] Cengiz Andan, Serif Aksin, Mehmet Rifat Goklu, Seyhmus Tunc. Factors related to blood loss in laparoscopic hysterectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1075-1080.
[2] Mahmoud Alalfy, Soha Talaat Hamed, Alaa Sobhi Abd El Ghani, Ahmed Elgazzar, Amr Abbassy, Ahmed S. S. A. Rashwan, Omar Nagy, Mohamed A Shalaby, Hatem Hassan, Asmaa Ibrahem, Hesham Kamal, Reham Mahrous, Eman Kamal. The accuracy of 3D-TUI and 3D power Doppler using Alalfy simple criteria in the diagnosis of placenta accreta spectrum[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1132-1140.
[3] Xue-Li Bai, Xia Cao. Postpartum hemorrhage and prolonged hyperfibrinolysis as complications of uterine cavernous hemangioma: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 987-990.
[4] Fikret Salık, Mustafa Bıçak. Can requirement for blood transfusion be predicted before delivery? Analysis of risk factors for blood transfusion in patients with postpartumhemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 572-577.
[5] Eren Akbaba. Can high transverse skin incision (Modified Maylard) be a new alternative in placenta accreta spectrum management with cesarean hysterectomy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 686-690.
[6] Yuki Yoshimura, Kentaro Nakayama, Kiyoka Sawada, Hitomi Yamashita, Kohei Nakamura, Tomoka Ishibashi, Masako Ishikawa, Sultana Razia, Seiya Sato, Satoru Kyo. A case of rectal injury due to vaginal pipe misinsertion during total laparoscopic hysterectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 194-197.
[7] Midori Fujisaki, Seishi Furukawa, Hiroshi Sameshima. Twin amniotic fluid discordance below 26 weeks of gestation for predicting adverse outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 53-58.
[8] X.R. Wang, Y.F. Wang, S.W. Kang, Y. Zhang. Treatment outcomes of uterine lesion resection versus hysterectomy for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 882-886.
[9] O. Sevket, T. Takmaz, A.C. Sevket, A. Toprak, P. Ozcan. Vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC): technique and mean 20 months outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 887-894.
[10] J.L. Liu, J.M. Chen, Y.F. Zheng, X.W. Zhang, R.X. Shi. 5 mm mini-incision laparoendoscopic single-site surgery of total hysterectomy: a report of five cases and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 895-899.
[11] S. Yamamura, K. Yamaguchi, I. Hayashi, N. Nagai, N. Sakane, A. Ikeda, M. Takakura, I. Emoto, M. Ujita, K. Kawasaki, K. Abiko, Y. Takao, K. Takakura, I. Konishi. Postpartum hemorrhage is associated with neonatal body weight, pre-pregnancy body mass index, and maternal weight gain[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 920-925.
[12] Ö. Koşar Can, Ö.T. Güler, Ü. Çabuş, D. Kılıç, C. Kabukçu. Evaluation of sexual functions and quality of life in female patients after hysterectomy for benign symptomatic diseases[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 693-700.
[13] E.D. Na, S.H. Choi, H. Park. Robotic laparoendoscopic single-site surgery for concurrent hysterectomy and cholecystectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 792-796.
[14] H. Takahashi, Y. Baba, R. Usui, S. Nagayama, K. Horie, A. Ohkuchi, S. Matsubara. Proteinuria as a novel risk factor for allogeneic blood transfusion irrespective of single or twin pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 709-713.
[15] P. Phangsuwan, P. Suprasert. Development of abnormal bowel function after simple hysterectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 744-748.
No Suggested Reading articles found!